关于转移性/不可切割的叶绿色细胞瘤和结质瘤的全身疗法和未来方向的最新情况
Imani Ghosh1, Olivia Benson1, Jorge H Hernandez-Felix1
1Developmental Therapeutics Clinic, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892, USA.
Cancers
|November 27, 2025
概括
新的向疗法和精准医学方法正在改变转移性叶绿细胞瘤和偏角细胞瘤 (PPGLs) 的管理. 这些进展为患有这些罕见的神经内分泌瘤的患者提供了改善的疾病控制和生活质量.
科学领域:
- 内分泌学和瘤学 在内分泌学和瘤学.
- 神经内分泌学神经内分泌学
- 分子瘤学分子瘤学
背景情况:
- 转移性或不可切除的肌肉染色细胞瘤和副瘤 (PPGLs) 是罕见的,具有挑战性的神经内分泌新生体,治疗选择有限.
- 传统的治疗方法,如手术,放射性核酸疗法和化疗,提供疾病稳定,但很少有持久的缓解.
研究的目的:
- 审查转移性PPGLs的不断变化的治疗环境.
- 突出系统性治疗的最新进展,包括放射性药物,向药物和免疫治疗.
- 讨论准确医学的新兴作用和根据分子形状量身定制的组合战略.
主要方法:
- 对转移性PPGL的全身治疗现有证据的审查.
- 来自研究新型治疗方法的临床试验发现的总结.
- 基于分子基因型和瘤表型的治疗策略的分析.
主要成果:
- 放射性药物 (I-MIBG,Lu-DOTATATE) 和细胞毒剂 (temozolomide) 仍然是重要的.
- 向药物,包括多酶抑制剂和HIF-2α抑制剂贝尔祖提凡,显示出显著的活性.
- 免疫疗法和新的方法,如PARP抑制正在研究中,有前途的组合正在出现.
结论:
- 转移性PPGL的治疗正在转向精准医学,采用量身定制的组合策略.
- 针对性治疗的进步和对分子驱动因素的更好理解正在改善结果.
- 转移性PPGL可能会成为一种更容易管理的慢性疾病,并改善生存率和生活质量.
关键词:
这是一种HIF-2α抑制剂.化学疗法 化疗 化疗免疫疗法 免疫疗法帕拉格里奥马马是什么意思叶染色细胞瘤 ( pheochromocytoma) 是一种致血性细胞瘤.放射性药物制品 放射性药物制品氨酸激酶抑制剂 氨酸激酶抑制剂更多相关视频
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
19.5K
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
14.1K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K